Clinical Edge Journal Scan

Rheumatoid meningitis should be considered with or without RA diagnosis


 

Key clinical point: Rheumatoid meningitis should be considered in adult patients with or without a diagnosis of rheumatoid arthritis (RA). This would help in timely diagnosis and treatment, thus improving its outcomes.

Major finding: Common clinical manifestations of rheumatoid meningitis were transient focal neurologic signs (64.28%), systemic symptoms (51.78%), episodic headaches (50.00%), and neuropsychiatric changes (47.32%). Brain imaging indicated frontal (82.69%) and parietal (77.88%) lobes as the most common lesion location. Laboratory findings included high levels of rheumatoid factor (89.71%), anticyclic citrulline peptide (89.47%), C-reactive protein (82.54%), and erythrocyte deposition rate (81.81%).

Study details: Findings are from a meta-analysis of 103 studies involving 130 cases of rheumatoid meningitis. RA was diagnosed previously in 83% of cases, whereas the remaining 17% of patients were diagnosed with RA during or after the first diagnosis of rheumatoid meningitis.

Disclosures: No outside funding was provided for this study. The authors did not report any conflicts of interest.

Source: Villa E et al. Eur J Neurol. 2021 May 9. doi: 10.1111/ene.14904 .

Recommended Reading

Lower SARS-CoV-2 vaccine responses seen in patients with immune-mediated inflammatory diseases
MDedge Rheumatology
Nintedanib slows interstitial lung disease in RA patients
MDedge Rheumatology
Gene variant confirmed as strong predictor of lung disease in RA
MDedge Rheumatology
Secondhand smoke in childhood and adulthood linked to increased risk of rheumatoid arthritis
MDedge Rheumatology
Patients with RA on rituximab at risk for worse COVID-19 outcomes
MDedge Rheumatology
Novel study links air pollution to increased risk of rheumatoid arthritis flares
MDedge Rheumatology
RA: ARCTIC REWIND findings do not support csDMARD dose tapering among patients in remission
MDedge Rheumatology
RA: Three doses of intravenous tranexamic acid more effective than single dose post-TKA
MDedge Rheumatology
Tofacitinib more effective than tocilizumab in bDMARD-naïve patients with methotrexate-refractory RA
MDedge Rheumatology
Early RA outcomes have improved in the current decade
MDedge Rheumatology